NCR3 anticorps (AA 19-135)

N° du produit ABIN7193777

L’anticorps anti-NCR3 Monoclonal produit chez le Souris a été validé pour ELISA, WB, IHC et FACS. Il convient pour la détection de NCR3 dans des échantillons provenant de Humain, Rat et Souris. }

Aperçu rapide pour NCR3 anticorps (AA 19-135) (ABIN7193777)

Antigène: NCR3 (Natural Cytotoxicity Triggering Receptor 3 (NCR3))

Reactivité: Humain, Rat, Souris

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp NCR3 est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Clone: 2D3B1

Détail du produit anti-NCR3 anticorps

Épitope: AA 19-135

Fonction: CD337 Antibody

Purification: Purified antibody

Immunogène: Purified recombinant fragment of human CD337 (AA: 19-135) expressed in HEK293-6e cells supernatant.

Isotype: IgG1

Information d'application

Indications d'application:

ELISA: 1/10000

FCM: 1/200 - 1/400

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Détails sur NCR3

Antigène: NCR3 (Natural Cytotoxicity Triggering Receptor 3 (NCR3))

Autre désignation: CD337

Sujet:

The protein encoded by this gene is a natural cytotoxicity receptor (NCR) that may aid NK cells in the lysis of tumor cells. The encoded protein interacts with CD3-zeta (CD247), a T-cell receptor. A single nucleotide polymorphism in the 5' untranslated region of this gene has been associated with mild malaria suceptibility. Three transcript variants encoding different isoforms have been found for this gene.

Poids moléculaire: 21.5 kDa

ID gène: 259197

UniProt: O14931

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process